We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Some Patients Can Discontinue Hypertension Drugs

By HospiMedica staff writers
Posted on 08 Mar 2001
Forty-two percent of patients whose hypertension medicine was discontinued were likely to maintain normal blood pressure for more than a year, according to a study in the February issue of the American Journal of Hypertension, a publication of the American Society of Hypertension. More...
The study was conducted by researchers at Alfred Hospital (Prahran, Australia).

The investigators noted that some doctors have difficulty in selecting patients for medication withdrawal and have concerns about patient safety and legal liability. Those most likely to be successfully withdrawn from medication are those with mildly elevated uncomplicated blood pressure that has been controlled by one medication. Patients must be carefully screened before they are selected and must be motivated and willing to accept lifestyle changes if needed.

The recommendations were based on an analysis of 12 major studies focusing on the withdrawal of antihypertensive therapy since the 1950s. When therapy is withdrawn, it is crucial, said the researchers, to start and continue long-term monitoring of patients in order to detect any return of high blood pressure. They speculate that most patients for whom withdrawal is appropriate may be those in whom therapy was commenced inappropriately. Because of this, it is important to confirm the diagnosis before starting treatment.

The U.S. Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure recommends that a decision to treat mild-to-moderate blood pressure elevation should be based on at least two blood pressure readings on at least three separate occasions.



Related Links:
American Society of Hypertension

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.